Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zydus
Pharma
Endo hits Zydus with patent suit over generic version of Chantix
Endo claims that Zydus violated its patent, which covers the method for producing its version of Chantix.
Zoey Becker
Aug 11, 2023 10:45am
Amgen chalks up appeals win against Otezla generics
Apr 20, 2023 11:08am
Several generics makers report shortages of Roche's Tamiflu
Dec 21, 2022 9:03am
BMS, generics companies face new suit over Revlimid 'monopoly'
Nov 22, 2022 11:38am
Zydus received three observations following an FDA inspection
Mar 10, 2022 10:52am
Amgen scores Otezla patent win, nabbing protection until 2028
Sep 21, 2021 10:00am